This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

Challenge to Peptide Manufacturing Technologies

Download nowget_app

Share this article

PeptiStar is a new peptide CDMO in Japan established in 2017, which has unique & innovative peptide synthesis technologies and state-of-the-art cGMP manufacturing facilities.

In this article, we introduce the benefits of our core synthesis technologies with some summary data: (i) Microwave synthesis - PeptiStar is the only one CDMO which can utilize microwave technology for large-scale manufacturing of peptides under cGMP; and (ii) STag synthesis (tag-assisted LPPS) - PeptiStar has innovative LPPS technology which enables one-pot synthesis even for long-chain peptides without precipitation, purification and concentration at each amino acid elongation step.

Last but not least, we also discuss PeptiStar's manufacturing strategy on how to choose Microwave and STag synthesis methods, depending on the production scale and the stages of development.

Download the full whitepaper by simply hitting the 'Download Now' link at the top of the page.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Virtual Scientific Forum

02 - 05 Mar 2021
Industry leaders and service providers share cutting-edge content and company expertise across the Oligonucleotide, Peptide, mRNA and Drug Delivery spectrum
Go to site